The poor outcome in high molecular risk,...

Blood 2019 / 12 Vol. 134; Iss. 23

The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib

O’Sullivan, Jennifer M., Hamblin, Angela, Yap, Christina, Fox, Sonia, Boucher, Rebecca, Panchal, Anesh, Alimam, Samah, Dreau, Helene, Howard, Kieran, Ware, Pauline, Cross, Nicholas C. P., McMullin,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
134
Journal:
Blood
DOI:
10.1182/blood.2019001861
Date:
December, 2019
File:
PDF, 847 KB
2019
Conversion to is in progress
Conversion to is failed